rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1998-8-4
|
pubmed:abstractText |
The aim of this study was to compare omeprazole (20 mg once daily) with placebo in the long-term prevention of gastroduodenal lesions induced by indomethacin, diclofenac and ketoprofen.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1125-8055
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
43-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9615264-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:9615264-Anti-Ulcer Agents,
pubmed-meshheading:9615264-Diclofenac,
pubmed-meshheading:9615264-Double-Blind Method,
pubmed-meshheading:9615264-Endoscopy, Digestive System,
pubmed-meshheading:9615264-Female,
pubmed-meshheading:9615264-Follow-Up Studies,
pubmed-meshheading:9615264-Gastric Mucosa,
pubmed-meshheading:9615264-Humans,
pubmed-meshheading:9615264-Indomethacin,
pubmed-meshheading:9615264-Intestinal Mucosa,
pubmed-meshheading:9615264-Ketoprofen,
pubmed-meshheading:9615264-Male,
pubmed-meshheading:9615264-Middle Aged,
pubmed-meshheading:9615264-Omeprazole,
pubmed-meshheading:9615264-Peptic Ulcer,
pubmed-meshheading:9615264-Rheumatic Diseases,
pubmed-meshheading:9615264-Safety,
pubmed-meshheading:9615264-Treatment Outcome
|
pubmed:year |
1998
|
pubmed:articleTitle |
Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
|
pubmed:affiliation |
Gastro-intestinal Unit, L. Sacco University Hospital, Milano, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|